Thioamide-modified peptides and uses thereof
US-11891425-B2 · Feb 6, 2024 · US
US10822372B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10822372-B2 |
| Application number | US-201615563871-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 30, 2016 |
| Priority date | Apr 3, 2015 |
| Publication date | Nov 3, 2020 |
| Grant date | Nov 3, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
One subject of the present invention is the use of a combination of a polyol (i) consisting of 12 carbon atoms and of a polyol (ii) consisting of 4 to 6 carbon atoms, as protein stabilizer. Another subject of the present invention is protein compositions comprising such a combination. A final subject of the present invention is a process for preparing protein compositions using such a combination.
Opening claim text (preview).
The invention claimed is: 1. A process of stabilizing proteins, comprising adding to a protein to be stabilized a combination of a polyol (i) consisting of 12 carbon atoms and of a polyol (ii) consisting of 4 to 6 carbon atoms, wherein said protein to be stabilized is a therapeutic protein selected from the group consisting of enzymes, cytokines, hormones, growth factors, plasma factors, vaccines, and antibodies, or is an enzyme intended for industrial use, and subjecting said protein to be stabilized to at least one of cryogenization, lyophilization treatments, and storage, wherein the polyol (i) is maltitol, and wherein a dry weight ratio of said polyol (i) to said polyol (ii) ranges from 50/50 to 75/25. 2. The process according to claim 1 , wherein said polyol (ii) comprises at least one of sorbitol, xylitol, and mannitol. 3. A process for preparing a protein composition comprising mixing together a protein, a polyol (i) consisting of 12 carbon atoms, and of a polyol (ii) consisting of 4 to 6 carbon atoms, wherein said protein is a therapeutic protein selected from the group consisting of enzymes, cytokines, hormones, growth factors, plasma factors, vaccines, and antibodies, or is an enzyme intended for industrial use, and subjecting said protein composition to at least one of cryogenization, lyophilization treatments, and storage, wherein the polyol (i) is maltitol, and wherein a dry weight ratio of said polyol (i) to said polyol (ii) ranges from 50/50 to 75/25. 4. The process according to claim 1 , wherein said protein to be stabilized is selected from the group consisting of erythropoietin, insulin, monoclonal antibodies, and growth hormones. 5. The process according to claim 1 , wherein said protein to be stabilized is a β-amylase.
by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents · CPC title
hydrolysing O- and S- glycosyl compounds (3.2.1) · CPC title
Beta-amylase (3.2.1.2) · CPC title
Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.